Testosterone and Its Metabolites in GID

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

January 31, 2008

Conditions
Transsexualism
Interventions
DRUG

testosterone undecanoate alone

1000 mg/12 weeks

DRUG

testosterone undecanoate plus letrozole

TU 1000 mg/12 weeks Letrozole 2.5 mg/day

DRUG

testosterone undecanoate plus dutasteride

TU 1000 mg/12weeks Dutasteride 0.5 mg/day

Trial Locations (1)

40138

Clinic of Obstetrics and Gynecology - S. Orsola Hospital, Bologna

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

Unita Complessa di Ostetricia e Ginecologia

OTHER